Showing results (11-20 of 36) with videos related to
Sort By:
Pageof 4
Plos One|October 26, 2021
Multiparametric MRI for assessment of early response to neoadjuvant sunitinib in renal cell carcinomaStephan Ursprung, Andrew N Priest, Fulvio Zaccagna, et al.Oncotarget|March 19, 2016
Tumor necrosis factor receptor 2-signaling in CD133-expressing cells in renal clear cell carcinomaRafia S Al-Lamki, Jun Wang, Jun Yang, et al.Nature Genetics|November 4, 2008
Common 5p15.33 and 6p21.33 variants influence lung cancer riskYufei Wang, Peter Broderick, Emily Webb, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2016
A Randomized Phase II/III Study of Naptumomab Estafenatox + IFNα versus IFNα in Renal Cell Carcinoma: Final Analysis with Baseline Biomarker Subgroup and Trend AnalysisRobert E Hawkins, Martin Gore, Yaroslav Shparyk, et al.European Journal of Human Genetics : EJHG|March 26, 2015
Deciphering associations for lung cancer risk through imputation and analysis of 12,316 cases and 16,831 controlsYufei Wang, Yongyue Wei, Valerie Gaborieau, et al.Cancer Research|March 12, 2016
Cytochrome P450 Allele CYP3A7*1C Associates with Adverse Outcomes in Chronic Lymphocytic Leukemia, Breast, and Lung CancerNichola Johnson, Paolo De Ieso, Gabriele Migliorini, et al.The Lancet. Oncology|October 21, 2015
Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trialRobert J Motzer, Thomas E Hutson, Hilary Glen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2012
Phase III, randomized, double-blind, placebo-controlled trial of gemcitabine/cisplatin alone or with sorafenib for the first-line treatment of advanced, nonsquamous non-small-cell lung cancerLuis G Paz-Ares, Bonne Biesma, David Heigener, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 2013
Tivozanib versus sorafenib as initial targeted therapy for patients with metastatic renal cell carcinoma: results from a phase III trialRobert J Motzer, Dmitry Nosov, Timothy Eisen, et al.Nature Genetics|April 4, 2008
Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1Christopher I Amos, Xifeng Wu, Peter Broderick, et al.Pageof 4